Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""CELL transplantation"" wg kryterium: Temat


Tytuł :
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Autorzy :
Kaddu-Mulindwa D; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany. Electronic address: .
Gödel P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Kutsch N; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Heger JM; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Scheid C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Borchmann P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Holtick U; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Held G; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Thurner L; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Bewarder M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Rixecker T; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Bittenbring JT; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Pokaż więcej
Źródło :
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e498-e506. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/methods
Lymphoma*/drug therapy
Lymphoma, B-Cell*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Consolidation Chemotherapy ; Humans ; Melphalan/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies ; Salvage Therapy/methods ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Autorzy :
Chong CY; City of Hope National Medical Center.
Pokaż więcej
Źródło :
Clinical journal of oncology nursing [Clin J Oncol Nurs] 2022 Jun 01; Vol. 26 (3), pp. 252-256.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/drug therapy
Humans ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
Autorzy :
Chu TH; BioMedical Sciences Graduate Program, Chonnam National University, Gwangju, Republic of Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea.
Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea.
Kim K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee JH; Gachon University Gil Medical Center, Incheon, Republic of Korea.
Mun YC; Ewha Womans University School of Medicine, Seoul, Republic of Korea.
Bang SM; Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Yoon DH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee HS; Kosin University Gospel Hospital, Busan, Republic of Korea.
Min CK; Department of Hematology, College of Medicine, Seoul St. Mary's Hematology Hospital, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul, 137-070, Republic of Korea. .
Lee JJ; BioMedical Sciences Graduate Program, Chonnam National University, Gwangju, Republic of Korea. .; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2022 Jun; Vol. 101 (6), pp. 1217-1226. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*
Plasmacytoma*/therapy
Humans ; Neoplasm Recurrence, Local/therapy ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Autorzy :
Spierings J; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Nihtyanova SI; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Derrett-Smith E; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Clark KEN; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
van Laar JM; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ong V; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Denton CP; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 May 05; Vol. 61 (5), pp. 1948-1956.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Hypertension, Pulmonary*/etiology
Scleroderma, Diffuse*/drug therapy
Scleroderma, Systemic*/drug therapy
Aged ; Dihydrotachysterol/therapeutic use ; Humans ; Male ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation.
Autorzy :
Gupta VK; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
El-Jawahri A; Division of Hematology and Oncology, Harvard Medical School, Boston, Massachusetts.
Orkev G; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
Johnson MH; Center for International Blood and Marrow Transplant Research Statistical Center, Milwaukee Campus, Milwaukee, Wisconsin.
Weinberg J; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Goodrich C; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Janakiram M; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
Sloan JM; Division of Hematology and Oncology, Boston University School of Medicine, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2022 May; Vol. 28 (5), pp. 276.e1-276.e5. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Human T-lymphotropic virus 1*
Leukemia-Lymphoma, Adult T-Cell*/therapy
Adult ; Humans ; Stem Cell Transplantation ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
Autorzy :
Seo ES; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Shin M; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lim H; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho HW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ju HY; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho YS; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yoo KH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Koo HH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee JW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Sung KW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Jul; Vol. 69 (7), pp. e29502. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Neuroblastoma*/drug therapy
Neuroblastoma*/therapy
3-Iodobenzylguanidine ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Follow-Up Studies ; Humans ; Infant ; Neoplasm, Residual/drug therapy ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Poor outcome of pediatric patients with acute myeloid leukemia harboring high FLT3/ITD allelic ratios.
Autorzy :
Qiu KY; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Liao XY; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Liu Y; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.; Hematologic Laboratory of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Huang K; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Li Y; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China.
Fang JP; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China. .; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China. .
Zhou DH; Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China. .; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, PR China. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2022 Jun 27; Vol. 13 (1), pp. 3679. Date of Electronic Publication: 2022 Jun 27.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Child ; Genetic Testing ; Humans ; Mutation ; Stem Cell Transplantation ; fms-Like Tyrosine Kinase 3/genetics
Czasopismo naukowe
Tytuł :
Is stem cell transplantation safe and effective in multiple sclerosis?
Autorzy :
Sharrack B; Department of Neurology and Sheffield NIHR Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust and University of Sheffield, Sheffield, UK .; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK .; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK .; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK .; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK .
Petrie J; Department of Neurology and Sheffield NIHR Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust and University of Sheffield, Sheffield, UK.; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
Coles A; Department of Neurology and Sheffield NIHR Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust and University of Sheffield, Sheffield, UK.; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
Snowden JA; Department of Neurology and Sheffield NIHR Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust and University of Sheffield, Sheffield, UK.; Clinical Trials Research Unit, University of Sheffield, Sheffield, UK.; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2022 Jun 09; Vol. 377, pp. e061514. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Sclerosis*/surgery
Humans ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
In vivo study to assess dosage of allogeneic pig retinal progenitor cells: Long-term survival, engraftment, differentiation and safety.
Autorzy :
Abud MB; Federal University of Goias, Goiania, GO, Brazil.; Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Baranov P; Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Patel S; ReNeuron, Pencoed, UK.
Hicks CA; ReNeuron, Pencoed, UK.
Isaac DLC; Federal University of Goias, Goiania, GO, Brazil.
Louzada RN; Federal University of Goias, Goiania, GO, Brazil.; Postgraduate Program in Surgical Science, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Dromel P; Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Singh D; Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Sinden J; ReNeuron, Pencoed, UK.
Ávila MP; Federal University of Goias, Goiania, GO, Brazil.
Young M; Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Jun; Vol. 26 (11), pp. 3254-3268. Date of Electronic Publication: 2022 Apr 28.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Retina*/metabolism
Animals ; Cell Differentiation/physiology ; Green Fluorescent Proteins/genetics ; Green Fluorescent Proteins/metabolism ; Stem Cell Transplantation ; Swine ; Swine, Miniature
Czasopismo naukowe
Tytuł :
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.
Autorzy :
Lazana I; Department of Haematological Medicine, King's College Hospital, London, UK.
Floro L; Department of Haematological Medicine, King's College Hospital, London, UK.
Christmas T; Department of Haematological Medicine, King's College Hospital, London, UK.
Shah S; Renal Unit, King's College Hospital, London, UK.
Bramham K; Renal Unit, King's College Hospital, London, UK.
Cuthill K; Department of Haematological Medicine, King's College Hospital, London, UK.
Bassett P; Statsconsultancy Ltd, London, UK.
Schey S; Department of Haematological Medicine, King's College Hospital, London, UK.; Department of Haematology, Guy's and St Thomas' Hospital, London, UK.
Kazmi M; Department of Haematological Medicine, King's College Hospital, London, UK.; Department of Haematology, Guy's and St Thomas' Hospital, London, UK.
Potter V; Department of Haematological Medicine, King's College Hospital, London, UK.
Pagliuca A; Department of Haematological Medicine, King's College Hospital, London, UK.
Streetly M; Department of Haematological Medicine, King's College Hospital, London, UK.; Department of Haematology, Guy's and St Thomas' Hospital, London, UK.
Benjamin R; Department of Haematological Medicine, King's College Hospital, London, UK. .; Department of Haematology, Guy's and St Thomas' Hospital, London, UK. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 959-965. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/methods
Multiple Myeloma*/complications
Multiple Myeloma*/therapy
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/therapy
Humans ; Retrospective Studies ; Stem Cell Transplantation/adverse effects ; Transplantation, Autologous/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.
Autorzy :
Shipton MJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Kinsella PM; Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Davis T; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Azzato F; Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Taiaroa G; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Szer J; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Routledge D; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Smibert O; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. .; Department of Infectious Diseases, Austin Health, Melbourne, VIC, Australia. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 1028-1030. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji :
Letter
MeSH Terms :
Brain Diseases*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Neurotoxicity Syndromes*
Humans ; Stem Cell Transplantation/adverse effects
Opinia redakcyjna
Tytuł :
A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma.
Autorzy :
Liu H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Liu W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Li R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Jiao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Huang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Lv R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Deng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
An G; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Sui W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Fu M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Zhao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
Zou D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2022 Jun; Vol. 57 (6), pp. 1017-1020. Date of Electronic Publication: 2022 Apr 07.
Typ publikacji :
Letter
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Lymphoma*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Deoxycytidine/analogs & derivatives ; Etoposide/therapeutic use ; Humans ; Stem Cell Transplantation ; Transplantation Conditioning ; Transplantation, Autologous
Opinia redakcyjna
Tytuł :
Durable remission for four pediatric patients with high-risk relapsed classical Hodgkin lymphoma treated with brentuximab vedotin plus gemcitabine but without autologous stem cell transplantation: A report from the Children's Oncology Group.
Autorzy :
Buhtoiarov IN; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic Children's, Cleveland, Ohio, USA.
Mba NI; Department of Pediatric Hematology and Oncology, Driscoll Children's Hospital, Corpus Christi, Texas, USA.
Santos CDL; Department of Pediatric Hematology and Oncology, Driscoll Children's Hospital, Corpus Christi, Texas, USA.
McCarten KM; Imaging and Radiation Oncology Core Rhode Island, Lincoln, Rhode Island, USA.
Metzger ML; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pei Q; Children's Oncology Group, Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
Bush R; Cytel, Inc., Waltham, Massachusetts, USA.
Baker K; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Kelly KM; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Cole PD; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Jun; Vol. 69 (6), pp. e29649. Date of Electronic Publication: 2022 Mar 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Hodgkin Disease*/drug therapy
Hodgkin Disease*/pathology
Immunoconjugates*/therapeutic use
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Brentuximab Vedotin ; Child ; Deoxycytidine/analogs & derivatives ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Salvage Therapy ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy.
Autorzy :
Pei XY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhao XY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu XF; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Lv M; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2022 Jun 01; Vol. 97 (6), pp. 762-769. Date of Electronic Publication: 2022 Mar 25.
Typ publikacji :
Journal Article
MeSH Terms :
Cytomegalovirus Infections*/etiology
Cytomegalovirus Infections*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Antiviral Agents/therapeutic use ; Basiliximab/therapeutic use ; Cytomegalovirus ; Humans ; Stem Cell Transplantation ; T-Lymphocytes, Cytotoxic
Czasopismo naukowe
Tytuł :
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Autorzy :
Mohan M; Medical College of Wisconsin, Froedtert Clinical Cancer Center, Division of Hematology/Oncology, Milwaukee, Wisconsin, USA.
Gundarlapalli S; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Szabo A; Medical College of Wisconsin, Froedtert Clinical Cancer Center, Division of Hematology/Oncology, Milwaukee, Wisconsin, USA.
Yarlagadda N; Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Kakadia S; Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Konda M; Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Jillella A; Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Fnu A; Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Ogunsesan Y; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Yarlagadda L; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Thalambedu N; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Munawar H; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Graziutti M; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Al Hadidi S; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Alapat D; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Thanendrarajan S; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Zangari M; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
van Rhee F; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Schinke C; Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2022 Jun 01; Vol. 97 (6), pp. E195-E198. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :
Letter
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/therapy
Receptors, Chimeric Antigen*
Bone Marrow ; Bone Marrow Transplantation ; Humans ; Neoplasm, Residual ; Stem Cell Transplantation ; Transplantation, Autologous
Opinia redakcyjna
Tytuł :
CRISPR-Edited Stem Cell Transplantation for HIV-Related Gene Modification In Vivo: A Systematic Review.
Autorzy :
Widjaya MA; Department of Biotechnology, College of Health Science, Asia University, Taichung, 41354, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 40402, Taiwan.
Ju JC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 40402, Taiwan. .; Translational Medicine Research Center, China Medical University Hospital, Taichung, 40402, Taiwan. .; Department of Bioinformatics and Medical Engineering, College of Information and Electrical Engineering, Asia University, Taichung, 41354, Taiwan. .; Department of Animal Science, National Chung Hsing University, Taichung, 40227, Taiwan. .
Lee SD; Department of Physical Therapy, China Medical University, Taichung, 40402, Taiwan. .; Department of Physical Therapy, Asia University, Taichung, 41354, Taiwan. .; School of Rehabilitation Medicine, Weifang Medical University, Shandong, 261053, China. .
Pokaż więcej
Źródło :
Stem cell reviews and reports [Stem Cell Rev Rep] 2022 Jun; Vol. 18 (5), pp. 1743-1755. Date of Electronic Publication: 2022 Feb 15.
Typ publikacji :
Journal Article; Review; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/genetics
HIV Infections*/therapy
Hematopoietic Stem Cell Transplantation*
CRISPR-Cas Systems/genetics ; Gene Editing/methods ; Humans ; Stem Cell Transplantation
Czasopismo naukowe
Tytuł :
Effects of an exercise program during pediatric stem cell transplantation: A randomized controlled trial.
Autorzy :
Smith C; Department of child health, The University of Arizona, College of Medicine, Phoenix, Arizona, USA.
Farhat R; Department of child health, The University of Arizona, College of Medicine, Phoenix, Arizona, USA.
Fern-Buneo A; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Purrington H; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Cobb E; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Matson L; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Kang P; Department of child health, The University of Arizona, College of Medicine, Phoenix, Arizona, USA.
Beebe K; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Campbell C; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Schwalbach C; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Salzberg D; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Miller H; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Adams R; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Ngwube A; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 May; Vol. 69 (5), pp. e29618. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Quality of Life*
Adolescent ; Adult ; Aftercare ; Child ; Child, Preschool ; Exercise ; Exercise Therapy ; Humans ; Patient Discharge ; Stem Cell Transplantation ; Young Adult
Czasopismo naukowe
Tytuł :
Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplant.
Autorzy :
Karam D; Department of Community Internal Medicine, Mayo Clinic Health System, Albert Lea, MN, USA.
Gertz M; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Lacy M; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Dispenzieri A; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Hayman S; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Dingli D; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Buadi F; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Kapoor P; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Kourelis T; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Warsame R; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Hogan W; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
Kumar S; Department of Hematology, Mayo Clinic, Rochester, MN, USA. .
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2022 May; Vol. 57 (5), pp. 803-809. Date of Electronic Publication: 2022 Mar 16.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cohort Studies ; Disease-Free Survival ; Humans ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation, Autologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Stem cell transplant for lymphoma - never too late?
Autorzy :
Cashen AF; Washington University School of Medicine and Siteman Cancer Center. .
Bartlett NL; Washington University School of Medicine and Siteman Cancer Center.
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2022 May 01; Vol. 107 (5), pp. 1024-1025. Date of Electronic Publication: 2022 May 01.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Lymphoma*/therapy
Humans ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Leucoderma and leucotrichia post stem cell transplant.
Autorzy :
Bowe S; Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Murphy LA; Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
O'Connor C; Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland .; Paediatrics and Child Health, University College Cork, Cork, Ireland.
Pokaż więcej
Źródło :
Archives of disease in childhood [Arch Dis Child] 2022 May; Vol. 107 (5), pp. 515. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Hypopigmentation*/etiology
Humans ; Stem Cell Transplantation/adverse effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies